Recombinant Mycobacterium smegmatis expressing an ESAT6-CFP10 fusion protein induces anti-mycobacterial immune responses and protects against Mycobacterium tuberculosis challenge in mice
- PMID: 20883320
- DOI: 10.1111/j.1365-3083.2010.02448.x
Recombinant Mycobacterium smegmatis expressing an ESAT6-CFP10 fusion protein induces anti-mycobacterial immune responses and protects against Mycobacterium tuberculosis challenge in mice
Abstract
The currently used vaccine against tuberculosis, Bacille Calmette-Guérin (BCG), has variable efficacy, so new vaccine development is crucial. In this study, we evaluated a recombinant vaccine prepared from non-pathogenic Mycobacterium smegmatis (rMS) that expresses a fusion of early secreted antigenic target 6-kDa antigen (ESAT6) and culture filtrate protein 10 (CFP10). C57BL/6 mice were immunized with the rMS expressing the ESAT6-CFP10 fusion protein (rM.S-e6c10) or with BCG. The mice in the rM.S-e6c10 group had a significantly higher titre of anti-ESAT6-CFP10 antibodies than did animals in the BCG or saline groups. Spleen cells from rM.S-e6c10-immunized mice exhibited a cytotoxic response to ESAT6 and CFP10-expressed target cells, but spleen cells from animals in the other groups did not. Levels of IFN-γ and IL-2 production by purified T cells from spleens were significantly higher in rM.S-e6c10 group than in BCG group. Finally, after M. tuberculosis (MTB)-challenged mice, dramatic reduction in the numbers of MTB colony-forming units (CFUs) in the lungs was observed for the mice immunized with the rMS. The protective efficacy of rM.S-e6c10 and BCG vaccination was similar based on measures of MTB burden and lung pathology. Our data indicate that the recombinant M. smegmatis vaccine expressing the ESAT6-CFP10 fusion protein has potential in clinic application.
© 2010 The Authors. Scandinavian Journal of Immunology © 2010 Blackwell Publishing Ltd.
Similar articles
-
[Immune response and protective efficacy induced by fusion protein ESAT6-CFP10 of M.tuberculosis in mice].Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2006 Jul;22(4):443-6. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2006. PMID: 16806004 Chinese.
-
[Immunoprophylaxis of recombinant Mycobacterium vaccae secreted MPT64 of Mycobacterium tuberculosis].Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2009 Mar;25(3):211-4. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2009. PMID: 19257983 Chinese.
-
[Immunity characteristics induced by a genetic vaccine expressing Ag85B-ESAT6 fusion protein].Zhonghua Jie He He Hu Xi Za Zhi. 2005 Nov;28(11):777-80. Zhonghua Jie He He Hu Xi Za Zhi. 2005. PMID: 16324275 Chinese.
-
[Novel vaccines against M. tuberculosis].Kekkaku. 2006 Dec;81(12):745-51. Kekkaku. 2006. PMID: 17240920 Review. Japanese.
-
Immunogenic potential of latency associated antigens against Mycobacterium tuberculosis.Vaccine. 2014 Feb 3;32(6):712-6. doi: 10.1016/j.vaccine.2013.11.065. Epub 2013 Dec 2. Vaccine. 2014. PMID: 24300592 Review.
Cited by
-
The current status, challenges, and future developments of new tuberculosis vaccines.Hum Vaccin Immunother. 2018 Jul 3;14(7):1697-1716. doi: 10.1080/21645515.2018.1458806. Epub 2018 May 14. Hum Vaccin Immunother. 2018. PMID: 29601253 Free PMC article. Review.
-
Immunogenicity of a recombinant Mycobacterium smegmatis vaccine expressing the fusion protein CMX in cattle from Goiás State, Brazil.J Vet Med Sci. 2014 Jul;76(7):977-84. doi: 10.1292/jvms.13-0338. Epub 2014 Mar 31. J Vet Med Sci. 2014. PMID: 24681608 Free PMC article. Clinical Trial.
-
Comparative evaluation of MPT83 (Rv2873) for T helper-1 cell reactivity and identification of HLA-promiscuous peptides in Mycobacterium bovis BCG-vaccinated healthy subjects.Clin Vaccine Immunol. 2011 Oct;18(10):1752-9. doi: 10.1128/CVI.05260-11. Epub 2011 Aug 18. Clin Vaccine Immunol. 2011. PMID: 21852544 Free PMC article.
-
Autophagy-Related Proteins Target Ubiquitin-Free Mycobacterial Compartment to Promote Killing in Macrophages.Front Cell Infect Microbiol. 2016 May 11;6:53. doi: 10.3389/fcimb.2016.00053. eCollection 2016. Front Cell Infect Microbiol. 2016. PMID: 27242971 Free PMC article.
-
The mc2-CMX vaccine induces an enhanced immune response against Mycobacterium tuberculosis compared to Bacillus Calmette-Guérin but with similar lung inflammatory effects.Mem Inst Oswaldo Cruz. 2016 Apr;111(4):223-31. doi: 10.1590/0074-02760150411. Mem Inst Oswaldo Cruz. 2016. PMID: 27074251 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources